难治性青光眼睫状体光凝疗效观察
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R779.63

基金项目:


Therapeutic effect observation on cyclophotocoagulation for refractory glaucoma
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:评价激光经巩膜睫状体光凝术(transscleral cyclo-photocoagulation,TSCPC)治疗难治性青光眼的临床疗效。方法:对36眼难治性青光眼采用低能量1.5~2.1W,多点数10~32的TSCPC,术后随访观察并记录眼压,视力,眼部自觉症状以及并发症,随访时间约3mo。结果:术前平均眼压62.89±17.36mmHg,最后随访平均眼压为21.13±7.06mmHg,经配对资料t检验,术前眼压与术后眼压相比,差别具有统计学意义(P<0.05)。手术有效率83%。指数以上视力10眼中术后6眼视力无变化,4眼视力提高。6眼眼压控制欠佳,行睫状体冷冻手术。术前所有眼痛的患者眼痛均消失或缓解,并发症少,程度轻,主要有色素膜炎,前房出血等,无眼球萎缩发生。结论:TSCPC是难治性青光眼的一种简单安全有效的治疗方法。

    Abstract:

    ·AIM:To evaluate the efficiency of transscleral cyclophotocoagulation(TSCPC)for refractory glaucoma.·METHODS:Retrospective analysis was made in 36 eyes with refractory glaucoma treated by TSCPC with lower energy power(1.5-2.1W)and more laser spots(10-32).Intraocular pressure(IOP),visual acuity,ocular symptoms and complications were observed after TSCPC.Patients were followed up for 3 months.·RESULTS:The mean preoperative IOP was 62.89±17.36mmHg which was significantly different from the final follow-up mean IOP,21.13±7.06mmHg(P<0.05).The success rate was 83%(30/36).Postoperative visual acuity remained unchanged in 6 eyes;improved in 4 eyes.The cyclocryotherapy were performed in 6 eyes whose IOP was not controlled.The pain sense disappeared or remarkably relieved.The main complications included mild uveitis and hyphemae.Atrophy of eyeball occurred in no eye.·CONCLUSION:TSCPC is a simple,safe and effective method for eyes with refractory glaucoma.·

    参考文献
    相似文献
    引证文献
引用本文

卢文胜,唐广贤.难治性青光眼睫状体光凝疗效观察.国际眼科杂志, 2010,10(8):1548-1549.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:
文章二维码